• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study.

作者信息

Krause Karoline, Mahamed Aos, Weller Karsten, Metz Martin, Zuberbier Torsten, Maurer Marcus

机构信息

Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin, Berlin, Germany; Autoinflammation Reference Center Charité, Charité - Universitätsmedizin, Berlin, Germany.

Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin, Berlin, Germany.

出版信息

J Allergy Clin Immunol. 2013 Sep;132(3):751-754.e5. doi: 10.1016/j.jaci.2013.04.008. Epub 2013 May 24.

DOI:10.1016/j.jaci.2013.04.008
PMID:23711544
Abstract
摘要

相似文献

1
Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study.
J Allergy Clin Immunol. 2013 Sep;132(3):751-754.e5. doi: 10.1016/j.jaci.2013.04.008. Epub 2013 May 24.
2
Refractory urticarial vasculitis responsive to anti-B-cell therapy.
Br J Dermatol. 2009 Feb;160(2):470-2. doi: 10.1111/j.1365-2133.2008.08990.x. Epub 2008 Dec 11.
3
Non-complementaemic urticarial vasculitis: successful treatment with the IL-1 receptor antagonist, anakinra.非补体血症性荨麻疹性血管炎：使用白细胞介素-1受体拮抗剂阿那白滞素成功治疗
Scand J Rheumatol. 2007 May-Jun;36(3):236-7. doi: 10.1080/03009740600938647.
4
[Hypocomplementemic vasculitis treated with dapsone].[用氨苯砜治疗的低补体血症性血管炎]
Ann Dermatol Venereol. 2010 Aug-Sep;137(8-9):541-5. doi: 10.1016/j.annder.2010.04.015. Epub 2010 Jun 18.
5
Urticarial vasculitis: a unique presentation.荨麻疹性血管炎：一种独特的表现。
South Med J. 2009 May;102(5):531-3. doi: 10.1097/SMJ.0b013e3181a0ae4c.
6
Clinical efficacy of reserpine as "add-on therapy" to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis.利血平作为抗组胺药的“附加疗法”用于顽固性慢性特发性荨麻疹和荨麻疹性血管炎患者的临床疗效。
J Dermatol. 2010 Sep;37(9):827-9. doi: 10.1111/j.1346-8138.2010.00881.x.
7
Hypocomplementaemic urticarial vasculitis: successful treatment with cyclophosphamide-dexamethasone pulse therapy.低补体血症性荨麻疹性血管炎：环磷酰胺-地塞米松冲击疗法成功治疗
Br J Dermatol. 1998 Oct;139(4):704-7. doi: 10.1046/j.1365-2133.1998.02473.x.
8
[Hypocomplementaemic urticarial vasculitis with bullous lesions and pericardial involvement].[伴有大疱性皮损及心包受累的低补体血症性荨麻疹性血管炎]
Ann Dermatol Venereol. 2015 Oct;142(10):557-62. doi: 10.1016/j.annder.2014.11.016. Epub 2015 Jan 19.
9
In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes.冷吡啉相关周期性综合征患者体内白细胞介素1β的调节
J Exp Med. 2009 May 11;206(5):1029-36. doi: 10.1084/jem.20082481. Epub 2009 Apr 13.
10
Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome.在 Schnitzler 综合征的 9 个月试验中，单克隆抗白细胞介素-1β抗体 canakinumab 持续有效。
Ann Rheum Dis. 2013 Oct;72(10):1634-8. doi: 10.1136/annrheumdis-2012-202192. Epub 2012 Oct 19.

引用本文的文献

1
Managing Urticarial Vasculitis: A Clinical Decision-Making Algorithm Based on Expert Consensus.荨麻疹性血管炎的管理：基于专家共识的临床决策算法
Am J Clin Dermatol. 2025 Jan;26(1):61-75. doi: 10.1007/s40257-024-00902-y. Epub 2024 Nov 13.
2
Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey.荨麻疹性血管炎与慢性自发性荨麻疹的鉴别诊断：一项国际德尔菲调查。
Clin Transl Allergy. 2023 Oct;13(10):e12305. doi: 10.1002/clt2.12305.
3
Biologicals in Treatment of Chronic Urticaria: A Narrative Review.
生物制剂治疗慢性荨麻疹：一篇叙述性综述
Indian Dermatol Online J. 2022 Dec 14;14(1):9-20. doi: 10.4103/idoj.idoj_145_22. eCollection 2023 Jan-Feb.
4
Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders.靶向白细胞介素-1 的生物制剂治疗免疫介导性疾病的安全性和疗效的系统评价。
Front Immunol. 2022 Jul 6;13:888392. doi: 10.3389/fimmu.2022.888392. eCollection 2022.
5
The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.逃之夭夭：分枝杆菌酸依赖的 Sec61 阻断如何使巨噬细胞衍生的白细胞介素 1β逃脱。
Front Immunol. 2022 Jan 26;12:788146. doi: 10.3389/fimmu.2021.788146. eCollection 2021.
6
Urticarial vasculitis.荨麻疹性血管炎
Int J Womens Dermatol. 2021 Jan 29;7(3):290-297. doi: 10.1016/j.ijwd.2021.01.021. eCollection 2021 Jun.
7
The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations.慢性荨麻疹的挑战 第2部分：药物治疗、慢性诱导性荨麻疹、特殊情况下的荨麻疹
World Allergy Organ J. 2021 Jun 3;14(6):100546. doi: 10.1016/j.waojou.2021.100546. eCollection 2021 Jun.
8
A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria.一种用于区分荨麻疹性血管炎与慢性自发性荨麻疹的新型组织病理学评分系统。
Clin Transl Allergy. 2021 Apr;11(2):e12031. doi: 10.1002/clt2.12031.
9
Real-World Experience on Omalizumab Treatment for Patients with Normocomplementemic Urticarial Vasculitis.奥马珠单抗治疗补体正常性荨麻疹性血管炎患者的真实世界经验
J Asthma Allergy. 2021 Apr 23;14:433-437. doi: 10.2147/JAA.S304099. eCollection 2021.
10
Off-label use of anti-IL-1 drugs in rheumatic diseases.抗白细胞介素-1 药物在风湿性疾病中的超适应证使用。
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211006584. doi: 10.1177/20587384211006584.